Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate

Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

1998 • 4,380 citations

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

2002 • 4,254 citations

Diagnosis of gastrointestinal stromal tumors: A consensus approach

2002 • 3,361 citations

Two Hundred Gastrointestinal Stromal Tumors

2000 • 2,510 citations

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

2004 • 1,629 citations

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

2001 • 1,267 citations

Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era

2005 • 1,251 citations

Biology of Gastrointestinal Stromal Tumors

2004 • 1,190 citations

Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

2005 • 725 citations

Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A European Organisation for Research and Treatment of Cancer–Italian Sarcoma Group–Australasian Gastrointestinal Trials Group Study

2005 • 280 citations

Surgery and Imatinib in the Management of GIST: Emerging Approaches to Adjuvant and Neoadjuvant Therapy

2004 • 238 citations

Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease

2002 • 198 citations

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

2005 • 188 citations

Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib

2005 • 170 citations

Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours

2004 • 158 citations

Salvage surgery for patients with recurrent gastrointestinal sarcoma

2000 • 153 citations

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients

2003 • 145 citations

Is there a role for surgery in patients with “unresectable” cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?

2003 • 131 citations

Gastric GI stromal tumors (GISTs): The role of surgery in the era of targeted therapy

2005 • 125 citations

Surgery for gastrointestinal stromal tumour in the post‐imatinib era

2005 • 25 citations

Safety and efficacy of percutaneous radio-frequency ablation (RFA) in patients (pts) with metastatic gastrointestinal stromal tumor (GIST) with clonal evolution of lesions refractory to imatinib mesylate (IM)

2004 • 23 citations

The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).

2003 • 22 citations

Gastro-intestinal stromal tumors (GIST) - Current aspects of surgical management

2004 • 19 citations

Surgery of residual disease following imatinib mesylate in advanced gastrointestinal stromal tumors (GIST)

2005 • 15 citations

Traitement chirurgical des GIST à l’heure du Glivec®

2004 • 11 citations

Imatinib may enable complete resection in previously unresectable or metastatic GIST

2004 • 7 citations

Clinical benefit of intermittent administration of imatinib in a patient with metastatic gastrointestinal stromal tumour

2005 • 1 citations